Patent classifications
A61K31/232
LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
PPAR AGONIST COMPLEX AND METHODS OF USE
Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.
PPAR AGONIST COMPLEX AND METHODS OF USE
Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
In various embodiments, the present invention provides pharmaceutical compositions and methods for treating cardiovascular-related disease.
COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORS
It is provided a method for stimulating the secretion of specialized pro-resolving mediators in a subject after the administration of a therapeutic phospholipid compositions such as CaPre®, wherein the composition also increases plasma levels of 17S-HDHA, PDX and 18RS-HEPE in the subject. Increased levels of protectins and resolvins are useful in protecting against many inflammatory-related diseases.